Impact of investigator initiated trials and industry sponsored trials on medical practice (IMPACT): rationale and study design
Open Access
- 2 October 2020
- journal article
- research article
- Published by Springer Nature in BMC Medical Research Methodology
- Vol. 20 (1) , 1-15
Abstract
Background: The German Research Foundation (DFG) and the Federal Ministry of Education and Research (BMBF) initiated large research programs to foster high quality clinical research in the academic area. These investigator initiated trials (IITs) cover important areas of medical research and often go beyond the scope of industry sponsored trials (ISTs). The purpose of this project was to understand to what extent results of randomized controlled IITs and ISTs have an impact on medical practice, measured by their availability for decisions in healthcare and their implementation in clinical practice. We aimed to determine study characteristics influencing a trial’s impact such as type of sponsor and place of conduct. In this article, we describe the rationale and design of this project and present the characteristics of the trials included in our study cohort. Methods: The research impact of the following sub-cohorts was compared: German IITs (funded by DFG and BMBF or by other German non-commercial organizations), international IITs (without German contribution), German ISTs, and international ISTs. Trials included were drawn from the DFG−/BMBF-Websites, the German Clinical Trials Register, and from ClinicalTrials.gov. Research impact was measured as follows: 1) proportion of published trials, 2) time to publication, 3) proportion of publications appropriately indexed in biomedical databases, 4) proportion of openly accessible publications, 5) broadness of publication’s target group, 6) citation of publications by systematic reviews or meta-analyses, and 7) appearance of publications or citing systematic reviews or meta-analyses in clinical practice guidelines. We also aimed to identify study characteristics associated with the impact of trials. Results: We included 691 trials: 120 German IITs, 200 International IITs, 171 German ISTs and 200 International ISTs. The median number of participants was 150, 30% were international trials and 70% national trials, 48% drug-trials and 52% non-drug trials. Overall, 72% of the trials had one pre-defined primary endpoint, 28% two or more (max. 36). Conclusions: The results of this project deepen our understanding of the impact of biomedical research on clinical practice and healthcare policy, add important insights for the efficient allocation of scarce research resources and may facilitate providing accountability to the different stakeholders involved.Keywords
All Related Versions
Funding Information
- German Research Foundation (BL 1395/2-1)
This publication has 45 references indexed in Scilit:
- Positive Outcomes Influence the Rate and Time to Publication, but Not the Impact Factor of Publications of Clinical Trial ResultsPLOS ONE, 2013
- Tracking the impact of research on policy and practice: investigating the feasibility of using citations in clinical guidelines for research evaluationBMJ Open, 2012
- Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trialsBMJ, 2010
- Reporting bias in medical research - a narrative reviewTrials, 2010
- Beyond citation analysis: a model for assessment of research impactJournal of the Medical Library Association, 2010
- How pharmaceutical industry funding affects trial outcomes: Causal structures and responsesSocial Science & Medicine, 2008
- Assessing outcomes of health and medical research: do we measure what counts or count what we can measure?Australia and New Zealand Health Policy, 2007
- Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic reviewBMJ, 2006
- Risk of cardiovascular events and rofecoxib: cumulative meta-analysisThe Lancet, 2004
- The file drawer problem and tolerance for null results.Psychological Bulletin, 1979